Product Recalls in Wyoming

Product recalls affecting Wyoming — including food, drugs, consumer products, medical devices, and vehicles distributed to Wyoming. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,553 recalls have been distributed to Wyoming in the last 12 months.

48,219 total recalls
2,553 in last 12 months

Showing 50015020 of 13,375 recalls

DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Estradiol Vaginal Inserts USP Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: Defective Delivery System: complaints for difficulty in pushing the plunger...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Distributed by: Chattem Recalled by...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund